NSE / BSEHealthcare
β‚Ή2072.70+18.80+0.92%
P/E83.0Mkt Capβ‚Ή38.57 K CrEV/EBITDA54.0

Narayana Hrudayalaya Limited

P/E83.0Mkt Capβ‚Ή38.57 K CrEV/EBITDA54.0
Company Profile

Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, ultrasonology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. Narayana Hrudayalaya Limited was incorporated in 2000 and is headquartered in Bengaluru, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 28 Jul 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Sign up free to view AI insights

Get Started

Rule-based from financial data. Not advice.

Price Historyβ–² 4.19% over 1Y
Monthly Returns

Historically, Jun has averaged the highest return (+8.6%); Sep the lowest (-0.6%).

Average from:
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026-6.5%Negative MonthJan 2026: -6.51%+3.7%Positive MonthFeb 2026: +3.71%-12.4%Negative MonthMar 2026: -12.42%+10.0%Positive MonthApr 2026: +10.00%+7.5%Positive MonthMay 2026: +7.52%+3.8%Positive MonthJun 2026: +3.80%+5.2%*Positive MonthJul 2026: +5.15%β€”β€”β€”β€”β€”
2025+8.9%Positive MonthJan 2025: +8.86%+4.2%Positive MonthFeb 2025: +4.17%+17.1%Positive MonthMar 2025: +17.10%+4.0%Positive MonthApr 2025: +3.98%-0.6%Neutral MonthMay 2025: -0.57%+24.2%Positive MonthJun 2025: +24.15%-11.7%Negative MonthJul 2025: -11.75%-8.5%Negative MonthAug 2025: -8.54%-1.1%Neutral MonthSep 2025: -1.05%+1.2%Neutral MonthOct 2025: +1.21%+10.8%Positive MonthNov 2025: +10.84%-2.8%Negative MonthDec 2025: -2.79%
2024+9.7%Positive MonthJan 2024: +9.68%+1.3%Neutral MonthFeb 2024: +1.35%-4.0%Negative MonthMar 2024: -4.02%+0.5%Neutral MonthApr 2024: +0.47%-7.6%Negative MonthMay 2024: -7.57%+1.1%Neutral MonthJun 2024: +1.10%+4.6%Positive MonthJul 2024: +4.65%+1.0%Neutral MonthAug 2024: +1.00%-1.6%Neutral MonthSep 2024: -1.56%+1.7%Neutral MonthOct 2024: +1.74%-0.3%Neutral MonthNov 2024: -0.29%+0.4%Neutral MonthDec 2024: +0.39%
2023-4.4%Negative MonthJan 2023: -4.37%+3.5%Positive MonthFeb 2023: +3.54%+2.9%Positive MonthMar 2023: +2.95%-1.7%Neutral MonthApr 2023: -1.65%+17.3%Positive MonthMay 2023: +17.29%+11.3%Positive MonthJun 2023: +11.29%+1.7%Neutral MonthJul 2023: +1.74%+2.8%Positive MonthAug 2023: +2.84%+4.2%Positive MonthSep 2023: +4.23%-8.1%Negative MonthOct 2023: -8.09%+23.2%Positive MonthNov 2023: +23.16%-2.2%Negative MonthDec 2023: -2.17%
2022+1.0%Neutral MonthJan 2022: +0.97%+6.3%Positive MonthFeb 2022: +6.26%+8.9%Positive MonthMar 2022: +8.95%-6.1%Negative MonthApr 2022: -6.08%-6.5%Negative MonthMay 2022: -6.46%-3.3%Negative MonthJun 2022: -3.26%+3.9%Positive MonthJul 2022: +3.91%+6.3%Positive MonthAug 2022: +6.31%+2.7%Positive MonthSep 2022: +2.74%+9.8%Positive MonthOct 2022: +9.81%-6.3%Negative MonthNov 2022: -6.25%+2.4%Positive MonthDec 2022: +2.45%
2021β€”β€”β€”β€”β€”+14.4%Positive MonthJun 2021: +14.35%-0.5%Neutral MonthJul 2021: -0.54%+10.6%Positive MonthAug 2021: +10.61%-7.2%Negative MonthSep 2021: -7.18%+3.7%Positive MonthOct 2021: +3.74%+14.9%Positive MonthNov 2021: +14.92%+6.7%Positive MonthDec 2021: +6.71%
AvgΒ±SD+1.7%Β±6.6%+3.8%Β±1.6%+2.5%Β±10.2%+1.3%Β±5.4%+2.0%Β±9.3%+8.6%Β±9.1%+0.5%Β±5.8%+2.4%Β±6.4%-0.6%Β±4.0%+1.7%Β±5.8%+8.5%Β±10.6%+0.9%Β±3.4%
* Current month β€” value will change until month-end.

Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β€” the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.

Seasonal Tendency

This aggregates every month by calendar position β€” all Januaries together, all Februaries together, and so on β€” to show whether a given month has leaned positive or negative historically. β€˜Simple’ counts each month as +1 or βˆ’1. β€˜Weighted’ gives larger moves more influence: +2 above +10%, βˆ’2 below βˆ’10%. With only 6 years of history for this asset, each month’s score reflects a small number of observations β€” read it as a historical tendency, not a reliable seasonal pattern.

Historical Trend

This tracks a running tally across the asset’s full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.

Year-to-Date ROI
Average from:
SD Γ—
Latest: 1.096x (2026)

Year-to-date return is calculated by dividing each day’s closing price by the price on January 1st of that year (or the asset’s first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β€” at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in β€œAverage from”, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή3.59 K Crβ–² 9.9%
EBITDA Growthβ€”
Net Profitβ‚Ή431.00 Crβ–² 1.4%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–² 736.8%
Revenue CAGR 5Y7.8%
EBITDA CAGR 5Y20.5%
Net Profit CAGR 5Y44.3%
NP Growth 1Y1.4%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή3.59 K Crβ€”β‚Ή431.00 Crβ€”β€”19.7%9.9%1.4%
Mar 2024β‚Ή3.27 K Crβ€”β‚Ή425.00 Crβ€”β€”23.1%10.2%59.8%
Mar 2023β‚Ή2.96 K Crβ€”β‚Ή266.00 Crβ€”β€”18.1%22.9%98.5%
Mar 2022β‚Ή2.41 K Crβ€”β‚Ή134.00 Crβ€”β€”10.9%45.7%-269.6%
Mar 2021β‚Ή1.66 K Crβ€”β‚Ή-79.00β€”β€”-7.3%-26.1%-216.2%
Mar 2020β‚Ή2.24 K Crβ€”β‚Ή68.00 Crβ€”β€”5.8%7.8%36.0%
Mar 2019β‚Ή2.08 K Crβ€”β‚Ή50.00 Crβ€”β€”4.3%12.4%-13.8%
Mar 2018β‚Ή1.85 K Crβ€”β‚Ή58.00 Crβ€”β€”5.2%12.3%-38.9%
Mar 2017β‚Ή1.65 K Crβ€”β‚Ή95.00 Crβ€”β€”9.0%12.0%66.7%
Mar 2016β‚Ή1.47 K Crβ€”β‚Ή57.00 Crβ€”β€”6.0%12.4%171.4%

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue / Net Sales1,0761,3081,4701,6461,8482,0772,2391,6552,4122,9653,2663,5903,746
Total Expenses9601,1821,2951,4271,6641,8811,9711,6762,1462,4712,6562,9053,006
EBIT / Operating Profit115126175219184196268-21266494609685740
OPM %11%10%12%13%10%9%12%-1%11%17%19%19%20%
Other Income25102141617197110495120139149
Finance Costs293823172643554845556598106
Depreciation & Amortisation556467687891128123119139161169182
Profit Before Tax5634861479579104-121206395503557601
Tax %36%38%34%35%39%37%35%-35%35%33%16%23%-
Net Profit / PAT36215795585068-79134266425431464
EPS (β‚Ή)1,107.251.052.774.652.862.453.31-3.856.541320.7721.1022.74
Dividend Payout %0%0%0%0%0%41%30%0%15%19%19%21%-

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Narayana Hrudayalaya Limitedthis co.β‚Ή38.57 K Crβ‚Ή3.59 K Cr83.0016.5654.039.9%
Sun Pharmaceutical Industries Ltd.β‚Ή4.15 L Crβ‚Ή23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.β‚Ή1.71 L Crβ‚Ή9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.β‚Ή1.33 L Crβ‚Ή9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.β‚Ή1.17 L Crβ‚Ή19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.β‚Ή1.05 L Crβ‚Ή8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limitedβ‚Ή1.00 L Crβ‚Ή2.66 K Cr144.0011.7696.8413.8%
Industry Averageβ€”β‚Ή3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Narayana Hrudayalaya Limited and the metrics that matter.

Browse the full Equiscale Academy